logo for Antengene

Antengene

Business Services · China · 329 Employees

View Company Info for Free

About

Headquarters

Soho Plaza 1065 W Zhongshan Road Suites 1206-12...

Phone Number

+86 1050951066

Revenue

<$5 Million

Industry

Business Services General Business Services

Most Recent Scoops

Dec 8 2022
New Hire
Sep 14 2022
Facilities Relocation / Expansion
See all scoops

Who is Antengene

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on inn ovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most advanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs.Read more

Antengene's Social MediaPopular SearchesAntengene CorpAntengeneAntengene Corporation LtdAntengene CoAntengene Biotech LLCSIC Code 28,283NAICS Code 54,541Show more

Antengene Org Chart

Jianming Mei

Founder, Chairman & Chief Executive Officer

PhoneEmail
Yiteng Liu

Chief Operating Officer

PhoneEmail
Amily Zhang

Chief Medical Officer

PhoneEmail

PhoneEmail

Is Antengene your ideal costumer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Similar Companies to Antengene

  1. 342
    $63.4M

    1

  2. 99
    $61.5M

    2

  3. 41
    $8.7M

    3

  4. 269
    $154.6M

    4

  5. 3,000
    $634M

    5

  6. 93
    <$5M

    6

See more similar companies
Illustration of an envelope

Antengene Tech Stack

A closer look at the technologies used by Antengene

Most Recent Scoops

Dec 8 2022
New Hire
Dec 8 2022
Lateral Move
Executive Move
Sep 14 2022
Facilities Relocation / Expansion
Mar 18 2022
Earnings
Sales
Jan 7 2022
Project
A high-level source has indicated that the biggest upcoming initiative will focus on the JP Morgan conference.
Events
See more scoops

Antengene News & Media

Read more news

Frequently Asked Questions regarding Antengene

Where is Antengene located?
Antengene's headquarters are located at Soho Plaza 1065 W Zhongshan Road Suites 1206-1209 Block B Zhongshan, Changning, Shanghai, China
What is Antengene's phone number?
Antengene's phone number is +86 1050951066
What is Antengene's official website?
Antengene's official website is www.antengene.com
What is Antengene's Revenue?
Antengene's revenue is <$5 Million
What is Antengene's SIC code?
Antengene's SIC: 28,283
What is Antengene's NAICS code?
Antengene's NAICS: 54,541
How many employees does Antengene have?
Antengene has 329 employees
What industry does Antengene belong to?
Antengene is in the industry of: Business Services General, Business Services
What is Antengene competition?
Antengene top competitors include: George Clinical, Theravance Biopharma, Immutep, Neuren Pharmaceuticals
What technology does Antengene use?
Some of the popular technologies that Antengene uses are: WordPress.org, PHP, bShare, Vue
Who is the CEO of Antengene?
Antengene's CEO is Jianming Mei
How do I contact Antengene?
Antengene contact info: Phone number: +86 1050951066 Website: www.antengene.com
What does Antengene do?

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on innovative first-in-class/best-in-class therapeutic medicines for cancer and other life-threatening diseases. Driven by its vision of "Treating Patients Beyond Borders", Antengene aims to provide the most a... dvanced anti-cancer drugs to patients in the Asia Pacific Region and around the world. Since initiating operations in 2017, Antengene has obtained 23 investigational new drug (IND) approvals in the US and in Asia, submitted 6 new drug applications (NDAs) in multiple Asia Pacific markets, with the NDA for XPOVIO® (selinexor) in China, South Korea, Singapore and Australia approved. Leveraging partnerships as well as in-house drug discovery, Antengene has built a broad and expanding pipeline of 15 clinical and pre-clinical assets. Antengene has global rights on 10 programs and Asia Pacific rights, including the Greater China region, on 5 programs.Read More

What are Antengene social media links?
Antengene Linkedin page
Is Antengene a public company?
Antengene is private company therefore does not currently have an official ticker symbol
See more information about Antengene

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.